Abstract
The role of clinical trials in the development of cancer treatments has increased over time. For decades, pharmaceutical companies, mainly from Western countries, drove clinical trials for new drugs developed for the treatment of cancer types that are predominant in Western countries. However, differences in the distribution of cancer types, patient backgrounds, and treatment procedures exist between Western and Eastern countries. To overcome these issues, clinical trial groups in Asian countries have also been established since the 20th century.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
